Pharmacokinetic Alterations After Severe Head Injury: Clinical Relevance

Author： Boucher B.A.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.35, Iss.3, 1998-09, pp. : 209-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Aspects of Pathophysiology and Cell Dysfunction after Severe Head Injury

By  

Current Pharmaceutical Design, Vol. 7, Iss. 15, 2001-10 ,pp. : 1475-1503

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Interactions with Rifampicin: Clinical Relevance

By Niemi M.  

Clinical Pharmacokinetics, Vol. 42, Iss. 9, 2003-01 ,pp. : 819-850

Adis International

Access to resources Recommend Favorite

Dexanabinol promising in severe head injury

By  

Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2131-2143

Bentham Science Publishers

Access to resources Recommend Favorite

Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2163-2176

Bentham Science Publishers

Access to resources Recommend Favorite